Business

November 11, 2013

Grifols to acquire Novartis' blood unit for $1.68 billion

Grifols, the Spanish biotherapeutics company with a large presence in the Triangle, announced Monday that it is acquiring Novartis' diagnostics business unit for $1.68 billion.

Related content

Comments

Editor's Choice Videos